{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:25:20Z","timestamp":1762496720551,"version":"build-2065373602"},"reference-count":171,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Chemotherapy drugs have significantly decreased breast cancer morbidity and mortality, but they have been associated with increased risk for adverse cardiovascular side effects, such as cardiotoxicity. These drugs generally fall under three broad categories: cell cycle inhibitors (ex. Anthracyclines, taxanes), human epidermal growth factor 2 (HER2) blockers (ex. Trastuzumab, pertuzumab), as well as other medications, such as the alkylating agent cyclophosphamide. This review analyzes the occurrence of specific cardiotoxic manifestations linked to increased heart failure risk, such as chest discomfort, edema, and dyspnea, as well as mechanisms of action, such as anthracycline inducing the generation of reactive oxygen species, for the aforementioned three drug categories. In particular, attention is given to anthracyclines and HER2 blockers, as they are two of the most commonly prescribed medications. On the other hand, the cardiotoxic effects of these medications have been found to be able to be mitigated by various exercise regimens, such as aerobic exercises, resistance training, and high intensity interval training. This review also examines the effectiveness of different regimens on alleviating post-chemotherapy cardiotoxicity in breast cancer patients, as well as the specific mechanisms involved, such as aerobic exercise being able to downregulate the expression of doxorubicin-induced pro-inflammatory factors (ex. Interleukin-8, cyclooxegenase-2, etc.). Moreover, the review points out the relative lack of cardiac rehabilitation programs specifically addressing the post-chemotherapeutic cardiotoxicity risks of breast cancer patients. Therefore, customized exercise regimens, accounting for breast cancer patient-specific medical profiles, should be developed to counteract against the adverse cardiovascular effects of chemotherapy.<\/jats:p>","DOI":"10.3389\/fcell.2025.1681702","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:22:17Z","timestamp":1762496537000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The mitigatory capabilities of exercise on breast cancer chemotherapy-induced cardiotoxicity"],"prefix":"10.3389","volume":"13","author":[{"given":"Chen-yue","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-yi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-yuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cui-feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1001\/jamacardio.2016.3841","article-title":"A population-based study of cardiovascular mortality following early-stage breast cancer","volume":"2","author":"Abdel-Qadir","year":"2017","journal-title":"JAMA Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1200\/JCO.2015.61.8413","article-title":"Long-term cardiac safety analysis of NCCTG N9831 (alliance) adjuvant trastuzumab trial","volume":"34","author":"Advani","year":"2016","journal-title":"J. Clin. Oncol. official J. Am. Soc. Clin. Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"784409","DOI":"10.3389\/fcvm.2022.784409","article-title":"Long-term risk of death from heart disease among breast cancer patients","volume":"9","author":"Agha","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11883-018-0711-4","article-title":"Cardiorespiratory fitness and cardiovascular disease prevention: an update","volume":"20","author":"Al-Mallah","year":"2018","journal-title":"Curr. Atheroscler. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/jnci\/djp440","article-title":"Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention","volume":"102","author":"Albini","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.cjco.2021.06.019","article-title":"Pertuzumab cardiotoxicity in patients with HER2-Positive cancer: a systematic review and meta-analysis","volume":"3","author":"Alhussein","year":"2021","journal-title":"CJC open"},{"key":"B7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40959-025-00362-1","article-title":"Challenges and opportunities for improving cardiovascular health in women with breast cancer: a review","volume":"11","author":"Ali","year":"2025","journal-title":"Cardio-oncology Lond. Engl."},{"key":"B8","doi-asserted-by":"publisher","first-page":"119760","DOI":"10.1016\/j.lfs.2021.119760","article-title":"An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity","volume":"280","author":"Anjos","year":"2021","journal-title":"Life Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American society of clinical oncology clinical practice guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J. Clin. Oncol. official J. Am. Soc. Clin. Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.21614\/chirurgia.112.4.457","article-title":"Results of 1-year diet and exercise interventions for ER+\/PR\u00b1\/HER2- breast cancer patients correlated with treatment type","volume":"112","author":"Artene","year":"2017","journal-title":"Chir. Buchar. Rom. 1990"},{"key":"B11","doi-asserted-by":"publisher","first-page":"H722","DOI":"10.1152\/ajpheart.01249.2004","article-title":"Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis","volume":"289","author":"Ascens\u00e3o","year":"2005","journal-title":"Am. J. physiology. Heart circulatory physiology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1042\/CS20100254","article-title":"Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats","volume":"120","author":"Ascens\u00e3o","year":"2011","journal-title":"Clin. Sci. Lond. Engl. 1979"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S0140-6736(23)00285-4","article-title":"Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials","volume":"401","year":"2023","journal-title":"Lancet London, Engl."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1113\/jphysiol.2011.213363","article-title":"Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training","volume":"589","author":"Baggish","year":"2011","journal-title":"J. physiology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.jacc.2019.07.079","article-title":"Cardiovascular toxicities of immune checkpoint inhibitors: JACC review topic of the week","volume":"74","author":"Ball","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/1534735418756193","article-title":"Meta-analysis of exercise training on vascular endothelial function in cancer survivors","volume":"17","author":"Beaudry","year":"2018","journal-title":"Integr. cancer Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1519\/JSC.0000000000003990","article-title":"Prescribing exercise in early-stage breast cancer during chemotherapy: a simple periodized approach to align with the cyclic phases of chemotherapy","volume":"36","author":"Bigaran","year":"2022","journal-title":"J. strength Cond. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11897-010-0004-x","article-title":"Galectin-3 in cardiac remodeling and heart failure","volume":"7","author":"Boer","year":"2010","journal-title":"Curr. heart Fail. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10549-019-05204-0","article-title":"Two-year follow-up of the OptiTrain randomised controlled exercise trial","volume":"175","author":"Bolam","year":"2019","journal-title":"Breast cancer Res. Treat."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/jnci\/djs317","article-title":"Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study","volume":"104","author":"Bowles","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"B21","first-page":"75","article-title":"Chemotherapy and cardiotoxicity","volume":"9","author":"Broder","year":"2008","journal-title":"Rev. Cardiovasc. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/1534735416683807","article-title":"Physical activity during and after adjuvant treatment for breast cancer: an integrative review of women's experiences","volume":"17","author":"Browall","year":"2018","journal-title":"Integr. cancer Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1249\/MSS.0b013e3181cfc908","article-title":"Effect of exercise on oxidative stress: a 12-month randomized, controlled trial","volume":"42","author":"Campbell","year":"2010","journal-title":"Med. Sci. sports Exerc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","article-title":"Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable","volume":"51","author":"Campbell","year":"2019","journal-title":"Med. Sci. sports Exerc."},{"key":"B25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/jnci\/djaa046","article-title":"Physical activity before, during, and after chemotherapy for high-risk breast cancer: relationships with survival","volume":"113","author":"Cannioto","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e2311673","DOI":"10.1001\/jamanetworkopen.2023.11673","article-title":"Adherence to cancer prevention lifestyle recommendations before, during, and 2 years after treatment for high-risk breast cancer","volume":"6","author":"Cannioto","year":"2023","journal-title":"JAMA Netw. open"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1161\/01.CIR.0000130926.51766.CC","article-title":"Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy","volume":"109","author":"Cardinale","year":"2004","journal-title":"Circulation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","article-title":"Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy","volume":"55","author":"Cardinale","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1016\/j.jacc.2012.07.068","article-title":"Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer","volume":"60","author":"Chen","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e2242660","DOI":"10.1001\/jamanetworkopen.2022.42660","article-title":"Association of physical activity with risk of mortality among breast cancer survivors","volume":"5","author":"Chen","year":"2022","journal-title":"JAMA Netw. open"},{"key":"B32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3760\/cma.j.cn112150-20200629-00944","article-title":"The relationship between resting heart rate and all-cause mortality among the Chinese oldest-old aged more than 80: a prospective cohort study","volume":"55","author":"Cheng","year":"2021","journal-title":"Zhonghua yu fang yi xue za zhi Chin. J. Prev. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"R424","DOI":"10.1152\/ajpregu.00636.2004","article-title":"Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart","volume":"289","author":"Chicco","year":"2005","journal-title":"Am. J. physiology. Regul. Integr. Comp. physiology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2146\/ajhp120735","article-title":"Pertuzumab for the treatment of human epidermal growth factor receptor type 2-positive metastatic breast cancer","volume":"70","author":"Chung","year":"2013","journal-title":"Am. J. health-system Pharm. AJHP official J. Am. Soc. Health-System Pharm."},{"key":"B35","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/jhh.2008.36","article-title":"Effect of 4 weeks of aerobic or resistance exercise training on arterial stiffness, blood flow and blood pressure in pre- and stage-1 hypertensives","volume":"22","author":"Collier","year":"2008","journal-title":"J. Hum. Hypertens."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1200\/JCO.2003.04.093","article-title":"Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes","volume":"21","author":"Courneya","year":"2003","journal-title":"J. Clin. Oncol. official J. Am. Soc. Clin. Oncol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"E629","DOI":"10.1152\/ajpendo.00171.2003","article-title":"Physiological role of AMP-Activated protein kinase in the heart: graded activation during exercise","volume":"285","author":"Coven","year":"2003","journal-title":"Am. J. physiology. Endocrinol. metabolism"},{"key":"B38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3322\/caac.21341","article-title":"Cardiotoxicity of anticancer treatments: epidemiology, detection, and management","volume":"66","author":"Curigliano","year":"2016","journal-title":"CA a cancer J. Clin."},{"key":"B39","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejca.2023.02.019","article-title":"Anthracycline-induced cardiotoxicity - are we about to clear this hurdle?","volume":"185","author":"Dempke","year":"2023","journal-title":"Eur. J. cancer (Oxford, Engl. 1990)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2324709613480346","DOI":"10.1177\/2324709613480346","article-title":"Cyclophosphamide-induced cardiomyopathy: a case report, review, and recommendations for management","volume":"1","author":"Dhesi","year":"2013","journal-title":"J. investigative Med. high impact case Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/0284186X.2019.1711164","article-title":"Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer","volume":"59","author":"Dyhl-Polk","year":"2020","journal-title":"Acta Oncol. Stockh. Swed."},{"key":"B42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40959-023-00172-3","article-title":"Mechanisms of trastuzumab induced cardiotoxicity - is exercise a potential treatment?","volume":"9","author":"Eaton","year":"2023","journal-title":"Cardio-oncology Lond. Engl."},{"key":"B43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bbi.2005.04.001","article-title":"Effect of exercise training on C-reactive protein in postmenopausal breast cancer survivors: a randomized controlled trial","volume":"19","author":"Fairey","year":"2005","journal-title":"Brain, Behav. Immun."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1158\/2159-8290.CD-20-1557","article-title":"Impact of HER2 heterogeneity on treatment response of early-stage HER2-Positive breast cancer: phase II neoadjuvant clinical trial of T-DM1 combined with pertuzumab","volume":"11","author":"Filho","year":"2021","journal-title":"Cancer Discov."},{"key":"B45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1470-2045(14)71159-3","article-title":"The cyclin-dependent kinase 4\/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1\/TRIO-18): a randomised phase 2 study","volume":"16","author":"Finn","year":"2015","journal-title":"Lancet. Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJMoa1607303","article-title":"Palbociclib and letrozole in advanced breast cancer","volume":"375","author":"Finn","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the national surgical adjuvant breast and bowel project P-1 study","volume":"97","author":"Fisher","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"B48","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1161\/CIRCULATIONAHA.122.062814","article-title":"Exercise for the prevention of anthracycline-induced functional disability and cardiac dysfunction: the BREXIT study","volume":"147","author":"Foulkes","year":"2023","journal-title":"Circulation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1001\/jama.240.15.1603","article-title":"Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals","volume":"240","author":"Friedman","year":"1978","journal-title":"JAMA"},{"key":"B50","doi-asserted-by":"publisher","first-page":"CD005001","DOI":"10.1002\/14651858.CD005001.pub3","article-title":"Exercise for women receiving adjuvant therapy for breast cancer","volume":"9","author":"Furmaniak","year":"2016","journal-title":"Cochrane database Syst. Rev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e202316","DOI":"10.21542\/gcsp.2023.16","article-title":"5-fluorouracil-induced coronary vasospasm: a cardiovascular magnetic resonance imaging case report","volume":"2023","author":"Garbis","year":"2023","journal-title":"Glob. Cardiol. Sci. and Pract."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/hypertensionaha.112.194050","article-title":"Impact of exercise training on preeclampsia: potential preventive mechanisms","volume":"60","author":"Genest","year":"1979","journal-title":"Hypertens. Dallas, Tex."},{"key":"B53","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.1038\/s41598-021-83877-8","article-title":"Cardioprotective effects of exercise training on doxorubicin-induced cardiomyopathy: a systematic review with meta-analysis of preclinical studies","volume":"11","author":"Ghignatti","year":"2021","journal-title":"Sci. Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"234","DOI":"10.2174\/157340311799960672","article-title":"Noninvasive diagnosis of chemotherapy related cardiotoxicity","volume":"7","author":"Gillespie","year":"2011","journal-title":"Curr. Cardiol. Rev."},{"key":"B55","doi-asserted-by":"publisher","first-page":"5700","DOI":"10.1200\/JCO.2009.23.2025","article-title":"High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 Cm or smaller","volume":"27","author":"Gonzalez-Angulo","year":"2009","journal-title":"J. Clin. Oncol. official J. Am. Soc. Clin. Oncol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/oxfordjournals.aje.a009901","article-title":"Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago heart association detection project in industry","volume":"149","author":"Greenland","year":"1999","journal-title":"Am. J. Epidemiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","article-title":"Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials","volume":"379","author":"Group","year":"2012","journal-title":"Lancet London, Engl."},{"key":"B58","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/eurheartj\/ehac244","article-title":"Guidelines and standards for the diagnosis and treatment of breast cancer of the Chinese anti-cancer association (2021 edition)","volume":"32","year":"2022","journal-title":"Chin. J. Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1534735419843999","DOI":"10.1177\/1534735419843999","article-title":"Effects of calorie restriction and voluntary exercise on doxorubicin-induced cardiotoxicity","volume":"18","author":"Hall","year":"2019","journal-title":"Integr. cancer Ther."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1001\/jama.283.23.3095","article-title":"Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: a randomized trial","volume":"283","author":"Hambrecht","year":"","journal-title":"JAMA"},{"key":"B61","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJM200002173420702","article-title":"Effect of exercise on coronary endothelial function in patients with coronary artery disease","volume":"342","author":"Hambrecht","year":"","journal-title":"N. Engl. J. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1177\/2047487313492069","article-title":"Galectin-3 increase in endurance athletes","volume":"21","author":"H\u00e4ttasch","year":"2014","journal-title":"Eur. J. Prev. Cardiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1136\/heartjnl-2017-312103","article-title":"Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention","volume":"104","author":"Henriksen","year":"2018","journal-title":"Heart British Card. Soc."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.mayocp.2014.05.013","article-title":"Evaluation and management of patients with heart disease and cancer: cardio-oncology","volume":"89","author":"Herrmann","year":"2014","journal-title":"Mayo Clin. Proc."},{"key":"B65","doi-asserted-by":"publisher","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","article-title":"Risk factors for doxorubicin-induced congestive heart failure","volume":"91","author":"Hoff","year":"1979","journal-title":"Ann. Intern. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1253\/circj.CJ-22-0779","article-title":"JCS\/CVIT\/JCC 2023 guideline focused update on diagnosis and treatment of vasospastic angina (coronary spastic angina) and coronary microvascular dysfunction","volume":"87","author":"Hokimoto","year":"2023","journal-title":"Circulation J. official J. Jpn. Circulation Soc."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1056\/NEJMoa1609709","article-title":"Ribociclib as first-line therapy for HR-Positive, advanced breast cancer","volume":"375","author":"Hortobagyi","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/2047487318811181","article-title":"Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients","volume":"26","author":"Howden","year":"2019","journal-title":"Eur. J. Prev. Cardiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2174\/0113892029305656240503045154","article-title":"Beyond the genome: deciphering the role of MALAT1 in breast cancer progression","volume":"25","author":"Hussain","year":"2024","journal-title":"Curr. genomics"},{"key":"B70","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1249\/MSS.0b013e318163744a","article-title":"Exercise preconditioning protects against doxorubicin-induced cardiac dysfunction","volume":"40","author":"Hydock","year":"2008","journal-title":"Med. Sci. sports Exerc."},{"key":"B71","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s12032-010-9536-x","article-title":"Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies","volume":"28","author":"Ibrahim","year":"2011","journal-title":"Med. Oncol. N. Lond. Engl."},{"key":"B72","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/nutrit\/nuz027","article-title":"The conundrum of dietary antioxidants in cancer chemotherapy","volume":"78","author":"Ilghami","year":"2020","journal-title":"Nutr. Rev."},{"key":"B73","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1046\/j.1523-5394.2002.104003.x","article-title":"Exercise counseling and programming preferences of cancer survivors","volume":"10","author":"Jones","year":"2002","journal-title":"Cancer Pract."},{"key":"B74","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"B75","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.breast.2017.04.003","article-title":"The effect of exercise on fatigue and physical functioning in breast cancer patients during and after treatment and at 6 months follow-up: a meta-analysis","volume":"33","author":"Juvet","year":"2017","journal-title":"Breastedinbg. Scotl."},{"key":"B76","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ccl.2019.07.004","article-title":"Fluoropyrimidine-associated cardiotoxicity","volume":"37","author":"Kanduri","year":"2019","journal-title":"Cardiol. Clin."},{"key":"B77","doi-asserted-by":"publisher","first-page":"S536","DOI":"10.4103\/0973-1482.183557","article-title":"Ventricular bigeminal rhythm associated with trastuzumab: a potential cardiac side effect","volume":"14","author":"Karaca","year":"2018","journal-title":"J. cancer Res. Ther."},{"key":"B78","doi-asserted-by":"publisher","first-page":"H1515","DOI":"10.1152\/ajpheart.00585.2010","article-title":"Short-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72","volume":"299","author":"Kavazis","year":"2010","journal-title":"Am. J. physiology. Heart circulatory physiology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/annonc\/mdw673","article-title":"Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Khosrow-Khavar","year":"2017","journal-title":"Ann. Oncol. official J. Eur. Soc. Med. Oncol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.119.044750","article-title":"Aromatase inhibitors and the risk of cardiovascular outcomes in women with breast cancer: a population-based cohort study","volume":"141","author":"Khosrow-Khavar","year":"2020","journal-title":"Circulation"},{"key":"B81","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1161\/CIRCULATIONAHA.112.100560","article-title":"Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues","volume":"126","author":"Khouri","year":"2012","journal-title":"Circulation"},{"key":"B82","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13643-024-02588-z","article-title":"Chemotherapy-related cardiotoxicity and its symptoms in patients with breast cancer: a scoping review","volume":"13","author":"Kim","year":"2024","journal-title":"Syst. Rev."},{"key":"B83","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijcard.2017.07.037","article-title":"Protective effects of acute exercise prior to doxorubicin on cardiac function of breast cancer patients: a proof-of-concept RCT","volume":"245","author":"Kirkham","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1161\/CIRCULATIONAHA.118.037357","article-title":"Human-induced pluripotent stem cell model of trastuzumab-induced cardiac dysfunction in patients with breast cancer","volume":"139","author":"Kitani","year":"2019","journal-title":"Circulation"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1200\/JCO.2014.58.7782","article-title":"Feasibility and cardiac safety of trastuzumab emtansine after anthracycline-based chemotherapy as (Neo)adjuvant therapy for human epidermal growth factor receptor 2-positive early-stage breast cancer","volume":"33","author":"Krop","year":"2015","journal-title":"J. Clin. Oncol. official J. Am. Soc. Clin. Oncol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1113\/EP091277","article-title":"Circulating Gal-3 and sST2 are associated with acute exercise-induced sustained endothelial activation: possible relevance for fibrosis development?","volume":"108","author":"Kr\u00f6pfl","year":"2023","journal-title":"Exp. Physiol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00262-020-02736-z","article-title":"Pembrolizumab and atezolizumab in triple-negative breast cancer","volume":"70","author":"Kwapisz","year":"2021","journal-title":"Cancer Immunol. Immunother. CII"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/ehf2.14368","article-title":"Heart failure with preserved ejection fraction phenogroup classification using machine learning","volume":"10","author":"Kyodo","year":"2023","journal-title":"Esc. heart Fail."},{"key":"B89","doi-asserted-by":"publisher","first-page":"CD011292","DOI":"10.1002\/14651858.CD011292.pub2","article-title":"Physical activity for women with breast cancer after adjuvant therapy","volume":"1","author":"Lahart","year":"2018","journal-title":"Cochrane database Syst. Rev."},{"key":"B90","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.0767-3981.2003.00215.x","article-title":"Vinorelbine-related cardiac events: a meta-analysis of randomized clinical trials","volume":"18","author":"Lapeyre-Mestre","year":"2004","journal-title":"Fundam. and Clin. Pharmacol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCRESAHA.117.305205","article-title":"Exercise and the cardiovascular system: clinical science and cardiovascular outcomes","volume":"117","author":"Lavie","year":"2015","journal-title":"Circulation Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1186\/s12885-019-5887-7","article-title":"Feasibility of high intensity interval training in patients with breast cancer undergoing anthracycline chemotherapy: a randomized pilot trial","volume":"19","author":"Lee","year":"2019","journal-title":"BMC cancer"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/annonc\/mdy533","article-title":"Pooled analysis of cardiac safety in patients with cancer treated with pertuzumab","volume":"30","author":"Lenihan","year":"2019","journal-title":"Ann. Oncol. official J. Eur. Soc. Med. Oncol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1517\/14740338.2015.1089231","article-title":"Trastuzumab-induced cardiotoxicity in elderly women with HER-2-positive breast cancer: a meta-analysis of real-world data","volume":"14","author":"Leung","year":"2015","journal-title":"Expert Opin. drug Saf."},{"key":"B95","doi-asserted-by":"publisher","first-page":"507","DOI":"10.7150\/ijbs.103810","article-title":"New insights into mitochondrial quality control in anthracycline-induced cardiotoxicity: molecular mechanisms, therapeutic targets, and natural products","volume":"21","author":"Li","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"102743","DOI":"10.1016\/j.cpcardiol.2024.102743","article-title":"New insights into cardioprotection in breast cancer patients undergoing physical exercise during chemotherapy: a systematic review and meta-analysis","volume":"49","author":"Linhares","year":"2024","journal-title":"Curr. problems Cardiol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1161\/01.cir.96.8.2641","article-title":"Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury","volume":"96","author":"Lipshultz","year":"1997","journal-title":"Circulation"},{"key":"B98","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the european hematology association (EHA), the european society for therapeutic radiology and oncology (ESTRO) and the international cardio-oncology society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur. heart J."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1179546817697983","DOI":"10.1177\/1179546817697983","article-title":"Diagnostic strategies for early recognition of cancer therapeutics-related cardiac dysfunction","volume":"11","author":"Manrique","year":"2017","journal-title":"Clin. Med. Insights. Cardiol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000521499","article-title":"Antibody-drug conjugates for breast cancer","volume":"45","author":"Marm\u00e9","year":"2022","journal-title":"Oncol. Res. Treat."},{"key":"B102","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10549-018-4663-8","article-title":"Highly favorable physiological responses to concurrent resistance and high-intensity interval training during chemotherapy: the OptiTrain breast cancer trial","volume":"169","author":"Mijwel","year":"2018","journal-title":"Breast cancer Res. Treat."},{"key":"B103","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s11764-019-00747-z","article-title":"High-intensity exercise during chemotherapy induces beneficial effects 12 months into breast cancer survivorship","volume":"13","author":"Mijwel","year":"2019","journal-title":"J. cancer Surviv. Res. Pract."},{"key":"B105","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab emtansine for residual invasive HER2-Positive breast cancer","volume":"380","author":"Minckwitz","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"B107","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1161\/01.hyp.38.2.232","article-title":"Pulse pressure compared with other blood pressure indexes in the prediction of 25-year cardiovascular and all-cause mortality rates: the Chicago heart association detection project in industry study","volume":"38","author":"Miura","year":"","journal-title":"Hypertens. Dallas, Tex."},{"key":"B108","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13102-025-01223-1","article-title":"Home-based exercise for chemotherapy-induced peripheral neuropathy: a feasibility study","volume":"17","author":"Miyata","year":"2025","journal-title":"BMC sports Sci. Med. and rehabilitation"},{"key":"B109","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1914510","article-title":"Trastuzumab deruxtecan in previously treated HER2-Positive breast cancer","volume":"382","author":"Modi","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/BCTT.S176070","article-title":"Epidemiological characteristics of and risk factors for breast cancer in the world","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Breast cancer (Dove Med. Press)"},{"key":"B111","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ijcard.2010.03.003","article-title":"Cardiac side-effects of cancer chemotherapy","volume":"144","author":"Monsuez","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1056\/NEJMra1100265","article-title":"Cardiovascular toxic effects of targeted cancer therapies","volume":"375","author":"Moslehi","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B113","doi-asserted-by":"publisher","first-page":"e005910","DOI":"10.1161\/CIRCHEARTFAILURE.119.005910","article-title":"Anthracycline cardiotoxicity","volume":"12","author":"Narezkina","year":"2019","journal-title":"Heart Fail."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1042\/CS20200301","article-title":"Molecular mechanisms of anthracycline cardiovascular toxicity","volume":"135","author":"Narezkina","year":"2021","journal-title":"Clin. Sci. Lond. Engl."},{"key":"B115","first-page":"1717","article-title":"Factors predicting trastuzumab-related cardiotoxicity in a real-world population of women with HER2+ breast cancer","volume":"33","author":"Naumann","year":"2013","journal-title":"Anticancer Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"876","DOI":"10.6061\/clinics\/2013(06)24","article-title":"Aerobic exercise improves the inflammatory profile correlated with cardiac remodeling and function in chronic heart failure rats","volume":"68","author":"Nunes","year":"2013","journal-title":"Clin. Sao Paulo, Braz."},{"key":"B117","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jjcc.2022.04.006","article-title":"Cancer therapeutics-related cardiovascular dysfunction: basic mechanisms and clinical manifestation","volume":"81","author":"Oikawa","year":"2023","journal-title":"J. Cardiol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/13543776.2016.1111872","article-title":"Taxane anticancer agents: a patent perspective","volume":"26","author":"Ojima","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"key":"B119","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jaccao.2022.01.101","article-title":"The role of cardioprotection in cancer therapy cardiotoxicity: JACC: cardiooncology state-of-the-art review","volume":"4","author":"Omland","year":"2022","journal-title":"JACC. CardioOncology"},{"key":"B120","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jaccao.2020.06.012","article-title":"How to diagnose and manage patients with fluoropyrimidine-induced chest pain: a single center approach","volume":"2","author":"Padegimas","year":"2020","journal-title":"JACC. CardioOncology"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3390\/antiox14091110","article-title":"Engineering antioxidants with pharmacological applications: biotechnological perspectives","volume":"14","author":"Paraschiv","year":"2025","journal-title":"Antioxidants Basel, Switz."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1249\/MSS.0000000000001544","article-title":"Exercise protects against cancer-induced cardiac cachexia","volume":"50","author":"Parry","year":"2018","journal-title":"Med. Sci. sports Exerc."},{"key":"B123","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jaccao.2022.08.003","article-title":"The continued importance of promoting exercise as part of oncology care for breast cancer patients","volume":"4","author":"Patel","year":"2022","journal-title":"JACC. CardioOncology"},{"key":"B124","doi-asserted-by":"publisher","first-page":"R64","DOI":"10.1186\/bcr2901","article-title":"Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study","volume":"13","author":"Patnaik","year":"2011","journal-title":"Breast cancer Res. BCR"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1200\/JCO.2007.13.5467","article-title":"Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the north central cancer treatment group N9831 adjuvant breast cancer trial","volume":"26","author":"Perez","year":"","journal-title":"J. Clin. Oncol. official J. Am. Soc. Clin. Oncol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"679","DOI":"10.4065\/83.6.679","article-title":"Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trials","volume":"83","author":"Perez","year":"","journal-title":"Mayo Clin. Proc."},{"key":"B127","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"B128","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/FJC.0000000000000574","article-title":"Effects of resistance exercise training on doxorubicin-induced cardiotoxicity","volume":"71","author":"Pfannenstiel","year":"2018","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/ejhf.2351","article-title":"Preventing heart failure: a position paper of the heart failure association in collaboration with the european association of preventive cardiology","volume":"24","author":"Piepoli","year":"2022","journal-title":"Eur. J. heart Fail."},{"key":"B130","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American society of echocardiography and the european association of cardiovascular imaging","volume":"27","author":"Plana","year":"2014","journal-title":"J. Am. Soc. Echocardiogr. official Publ. Am. Soc. Echocardiogr."},{"key":"B131","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1111\/jcmm.15194","article-title":"Mitochondrial biogenesis: an update","volume":"24","author":"Popov","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejca.2019.11.023","article-title":"Trastuzumab emtansine (T-DM1)-associated cardiotoxicity: pooled analysis in advanced HER2-positive breast cancer","volume":"126","author":"Pond\u00e9","year":"2020","journal-title":"Eur. J. cancer (Oxford, Engl. 1990)"},{"key":"B133","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1128\/MCB.00426-14","article-title":"Insulin receptor substrates are essential for the bioenergetic and hypertrophic response of the heart to exercise training","volume":"34","author":"Riehle","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10741-017-9653-0","article-title":"Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients","volume":"23","author":"Ruggeri","year":"2018","journal-title":"Heart Fail. Rev."},{"key":"B135","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.hrtlng.2019.05.016","article-title":"Heart failure symptom clusters and quality of life","volume":"48","author":"Salyer","year":"2019","journal-title":"Heart and lung J. Crit. care"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1758835918780140","DOI":"10.1177\/1758835918780140","article-title":"5-fluorouracil and cardiotoxicity: a review","volume":"10","author":"Sara","year":"2018","journal-title":"Ther. Adv. Med. Oncol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3238\/arztebl.2014.0161","article-title":"Cardiotoxicity and oncological treatments","volume":"111","author":"Schlitt","year":"2014","journal-title":"Dtsch. Arzteblatt Int."},{"key":"B138","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1158\/1055-9965.EPI-07-0058","article-title":"Exercise effect on oxidative stress is independent of change in estrogen metabolism","volume":"17","author":"Schmitz","year":"2008","journal-title":"Cancer Epidemiol. biomarkers and Prev. a Publ. Am. Assoc. Cancer Res. cosponsored by Am. Soc. Prev. Oncol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1249\/MSS.0b013e3181e0c112","article-title":"American college of sports medicine roundtable on exercise guidelines for cancer survivors","volume":"42","author":"Schmitz","year":"2010","journal-title":"Med. Sci. sports Exerc."},{"key":"B140","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jaccao.2022.07.006","article-title":"Optimal timing of a physical exercise intervention to improve cardiorespiratory fitness: during or after chemotherapy","volume":"4","author":"Schoot","year":"2022","journal-title":"JACC. CardioOncology"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.117.024671","article-title":"Exercise therapy and cardiovascular toxicity in cancer","volume":"137","author":"Scott","year":"2018","journal-title":"Circulation"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1200\/JCO.2002.20.5.1215","article-title":"Cardiac dysfunction in the trastuzumab clinical trials experience","volume":"20","author":"Seidman","year":"2002","journal-title":"J. Clin. Oncol. official J. Am. Soc. Clin. Oncol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"118698","DOI":"10.1016\/j.lfs.2020.118698","article-title":"Aerobic exercise training attenuates doxorubicin-induced ultrastructural changes in rat ventricular myocytes","volume":"264","author":"Sequeira","year":"2021","journal-title":"Life Sci."},{"key":"B99","article-title":"Congestive heart failure","author":"Shams","year":"2024","journal-title":"StatPearls"},{"key":"B144","first-page":"352","article-title":"Pathobiology and evolving therapies of coronary artery vasospasm","volume-title":"Proceedings","author":"Sheth","year":"2021"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1007\/s00394-017-1489-9","article-title":"Serum antioxidant capacity, biochemical profile and body composition of breast cancer survivors in a randomized mediterranean dietary intervention study","volume":"57","author":"Skouroliakou","year":"2018","journal-title":"Eur. J. Nutr."},{"key":"B146","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1126\/science.2470152","article-title":"Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer","volume":"244","author":"Slamon","year":"1989","journal-title":"Sci. (New York, N.Y.)"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0910383","article-title":"Adjuvant trastuzumab in HER2-positive breast cancer","volume":"365","author":"Slamon","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B148","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"S\u00f8rlie","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B149","doi-asserted-by":"publisher","first-page":"507","DOI":"10.4172\/2155-9880.1000507","article-title":"Creating a biomarker panel for early detection of chemotherapy related cardiac dysfunction in breast cancer patients","volume":"8","author":"Srikanthan","year":"2017","journal-title":"J. Clin. and Exp. Cardiol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s12012-025-10037-z","article-title":"Safety of permissive cardiotoxicity of trastuzumab in patients with breast cancer: a systematic review and meta-analysis","volume":"25","author":"Taha","year":"2025","journal-title":"Cardiovasc. Toxicol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1055\/s-0034-1398494","article-title":"Autophagic adaptations to long-term habitual exercise in cardiac muscle","volume":"36","author":"Tam","year":"2015","journal-title":"Int. J. sports Med."},{"key":"B152","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1200\/JCO.2015.65.1505","article-title":"Breast cancer therapy-related cardiac dysfunction in adult women treated in routine clinical practice: a population-based cohort study","volume":"34","author":"Thavendiranathan","year":"2016","journal-title":"J. Clin. Oncol. official J. Am. Soc. Clin. Oncol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/annonc\/mdy300.008","article-title":"Updated meta-analysis of randomized controlled trials (RCTs) to determine the CDK 4\/6 inhibitors associated venous thromboembolism (VTE) risk in hormone receptor-positive breast cancer (BC) patients","volume":"29","author":"Thein","year":"2018","journal-title":"Ann. Oncol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2174\/0109298665322427240906060626","article-title":"Revealing the molecular signatures of miR-185-5p on breast cancer cells using proteomic analysis","volume":"31","author":"Torun","year":"2024","journal-title":"Protein peptide Lett."},{"key":"B155","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.3390\/cancers14092288","article-title":"The beneficial role of physical exercise on anthracyclines induced cardiotoxicity in breast cancer patients","volume":"14","author":"Tranchita","year":"2022","journal-title":"Cancers"},{"key":"B156","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s11357-011-9277-6","article-title":"Oxidative stress in older adults: effects of physical fitness","volume":"34","author":"Traustad\u00f3ttir","year":"2012"},{"key":"B157","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1056\/NEJMoa2105215","article-title":"Adjuvant olaparib for patients with BRCA1-or BRCA2-Mutated breast cancer","volume":"384","author":"Tutt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B158","doi-asserted-by":"publisher","first-page":"100760","DOI":"10.1016\/j.ctarc.2023.100760","article-title":"Cardiotoxicity in breast cancer treatment: causes and mitigation","volume":"37","author":"Valiyaveettil","year":"2023","journal-title":"Cancer Treat. Res. Commun."},{"key":"B159","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.3390\/curroncol28050351","article-title":"Exercise to reduce anthracycline-mediated cardiovascular complications in breast cancer survivors","volume":"28","author":"Varghese","year":"2021","journal-title":"Curr. Oncol. Tor. Ont."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1056\/NEJMoa1209124","article-title":"Trastuzumab emtansine for HER2-positive advanced breast cancer","volume":"367","author":"Verma","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B161","doi-asserted-by":"publisher","first-page":"E519","DOI":"10.1152\/ajpendo.00617.2013","article-title":"Exercise training boosts eNOS-dependent mitochondrial biogenesis in mouse heart: role in adaptation of glucose metabolism","volume":"306","author":"Vettor","year":"2014","journal-title":"Am. J. physiology. Endocrinol. metabolism"},{"key":"B104","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1056\/NEJMoa1703643","article-title":"Adjuvant pertuzumab and trastuzumab in early HER2-Positive breast cancer","volume":"377","author":"von Minckwitz","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B162","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fonc.2012.00062","article-title":"Trastuzumab: updated mechanisms of action and resistance in breast cancer","volume":"2","author":"Vu","year":"2012","journal-title":"Front. Oncol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/MPH.0000000000001112","article-title":"Aerobic exercise during early murine doxorubicin exposure mitigates cardiac toxicity","volume":"40","author":"Wang","year":"2018","journal-title":"J. Pediatr. hematology\/oncology"},{"key":"B164","doi-asserted-by":"publisher","first-page":"336","DOI":"10.31083\/j.rcm2411336","article-title":"Recent advances in the mechanisms of cell death and dysfunction in doxorubicin cardiotoxicity","volume":"24","author":"Wang","year":"2023","journal-title":"Rev. Cardiovasc. Med."},{"key":"B165","doi-asserted-by":"publisher","first-page":"e39740","DOI":"10.2196\/39740","article-title":"Improving cognitive function through high-intensity interval training in breast cancer patients undergoing chemotherapy: protocol for a randomized controlled trial","volume":"12","author":"Wilson","year":"2023","journal-title":"JMIR Res. Protoc."},{"key":"B166","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/1534735408322848","article-title":"Acute exercise protects against doxorubicin cardiotoxicity","volume":"7","author":"Wonders","year":"2008","journal-title":"Integr. cancer Ther."},{"key":"B167","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10557-021-07181-3","article-title":"The molecular mechanisms of cardiotoxicity induced by HER2, VEGF, and tyrosine kinase inhibitors: an updated review","volume":"36","author":"Wu","year":"2022","journal-title":"Cardiovasc. drugs Ther."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/cancers12051102","article-title":"Early moderate intensity aerobic exercise intervention prevents doxorubicin-caused cardiac dysfunction through inhibition of cardiac fibrosis and inflammation","volume":"12","author":"Yang","year":"2020","journal-title":"Cancers"},{"key":"B169","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines:tThe Task torceffor cancer treatments and cardiovascular toxicity of the European Sociesy of Cardiclogy (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur. heart J."},{"key":"B170","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s11888-013-0188-z","article-title":"Role of apoptosis in Colon cancer biology, therapy, and prevention","volume":"9","author":"Zhang","year":"2013","journal-title":"Curr. colorectal cancer Rep."},{"key":"B171","doi-asserted-by":"publisher","first-page":"104997","DOI":"10.1016\/j.ijnurstu.2025.104997","article-title":"Effectiveness of exercise-based interventions in preventing cancer therapy-related cardiac dysfunction in patients with breast cancer: a systematic review and network meta-analysis","volume":"163","author":"Zhang","year":"2025","journal-title":"Int. J. Nurs. Stud."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1681702\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:22:19Z","timestamp":1762496539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1681702\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":171,"alternative-id":["10.3389\/fcell.2025.1681702"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2025.1681702","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"article-number":"1681702"}}